What if we could map our immune system in order to develop drugs that can help our bodies fight cancer and other diseases? Immunai is a biotechnology company that uses Artificial Intelligence technology to map the human immune system and accelerate the development of new immunotherapies for cancer and autoimmune diseases.
On this episode of NVIDIA’s AI Podcast, host Noah Kravitz spoke with Luis Voloch, CTO and Co-Founder of Immunai, about approaching immune system challenges with a Machine Learning and Data Science mindset.
